177 - New Developments in Vaccines

Moderator(s)

• 

  Flor Munoz, MD, MSc

  Associate Professor of Pediatrics
  Pediatrics
  Baylor College of Medicine
  Houston, TX, United States
• 

  Angela Branche, MD

  Associate Professor of Medicine
  Medicine
  University of Rochester
  Rochester, NY, United States

Presentations:

• 1:45 PM – 2:00 PM US ET

  Real-Life Impact of Pneumococcal Conjugate Vaccines (PCVs) on Hospitalization of Young Children with RSV-Associated Community-acquired Alveolar Pneumonia (CAAP)
  

  Presenting Author: Ron Dagan, Professor MD (he/him/his) – Ben-Gurion University of the Negev

  Co-Author: Bart Adriaan van der Beek, Data analyst – Ben-Gurion University of the Negev

  Co-Author: David Greenberg, Professor MD – Soroka University Medical Center, Pediatric Infectious Disease Unit

  Co-Author: Shalom Ben-Shimol, Professor MD – Soroka University Medical Center
• 2:00 PM – 2:15 PM US ET

  Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
  

  Presenting Author: James A. Baber, MBChB, MPH (he/him/his) – Pfizer Vaccine Clinical Research

  Co-Author: Karen Quan, BSc, MBBS, DPM – Pfizer Vaccine Clinical Research

  Co-Author: Eugene Athan, MBBS, MPH, PhD – Barwon Health

  Co-Author: Robert Scott, MD – University of the Sunshine Coast

  Co-Author: Anna Jaques, MPH – Pfizer Vaccine Clinical Research

  Co-Author: Qin Jiang, PhD – Pfizer

  Co-Author: Wen Li, PhD – Pfizer Vaccine Clinical Research

  Co-Author: David Cooper, PhD – Pfizer

  Co-Author: Mark W. Cutler, PhD – Pfizer Inc

  Co-Author: Elena Kalinina, PhD – Pfizer

  Co-Author: Annaliesa S. Anderson, PhD – Pfizer

  Co-Author: Kena A. Swanson, Ph.D. – Pfizer

  Co-Author: William C. Gruber, MD – Pfizer

  Co-Author: Alejandra C. Gurtman, M.D. – Pfizer

  Co-Author: Beate Schmoele-Thoma, MD – Pfizer
• 2:15 PM – 2:30 PM US ET

  Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV among US Infants
  

  Co-Author: Ahuva Hanau, BS – Policy Analysis Inc.

  Co-Author: Kimberly M. Shea, Ph.D., M.P.H. – Pfizer Inc.

  Co-Author: Derek Weycker, Ph.D. – Policy Analysis Inc.

  Co-Author: Mark Atwood, MS – Policy Analysis Inc (PAI)

  Co-Author: Erin Quinn, BS – Policy Analysis Inc.

  Co-Author: Emily Kutrieb, B.A. – Policy Analysis Inc.

  Co-Author: Jessica E. Atwell, PhD, MPH – Pfizer

  Co-Author: Alejandro D. Cane, MD, PhD – Pfizer

  Co-Author: Bradford J. Gessner, M.D., M.P.H. – Pfizer Biopharma Group

  Co-Author: Sarah J. Pugh, PhD, MPH – Pfizer, Inc.

  Presenting Author: Amy W. Law, PharmD – Pfizer, Inc.
• 2:30 PM – 2:45 PM US ET

  RSV Prophylaxis for 29-34 Gestational Preemies. Are Current Guidelines Justified? Lessons from an Israeli Multicenter Off-seasonal Study
  

  Co-Author: Keren Armoni Domany, md – wolfson medical center

  Co-Author: Avigdor Mandelberg, MD – Department of Pediatrics, Edith Wolfson Medical Center, Holon /Sackler School of Medicine, Tel-Aviv University, Tel-Aviv

  Co-Author: Nitzan Burrack, md – Pediatric Pulmonary Unit, Soroka University Medical Center, Beer-Sheva, Israel

  Co-Author: Inbal Tripto Golan, md – Pediatric Pulmonary Unit, Soroka University Medical Center, Beer-Sheva, Israel

  Co-Author: Kamal Masarweh, md – Pediatric Pulmonary Institute and CF Center, The Ruth Rappaport Children's Hospital, Haifa, Israel

  Co-Author: Mika Rochman, md – Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Israel

  Co-Author: Dario Prais, md – Pulmonary Institute, Schneider Children’s Medical Center, Israel

  Co-Author: Meirav Mor, MD – Schneider Children's Medical Center of Israel; Tel Aviv University

  Co-Author: Moran Weinberger Opek, md – Department of Pediatrics, Samson Assuta Ashdod University Hospital, Ashdod, Israel 12. Saint Vincent De Paul Hospital, Israel

  Co-Author: Elias Nasrallah, md – Saint Vincent De Paul Hospital, Israel

  Co-Author: Orli Megged, md – Shaare Zedek Medical Center (affiliated with Hebrew University, Hadassah School of Medicine), Jerusalem, Israel.

  Co-Author: Rachel Shatzman Steuerman, md – Pediatric Infectious Disease Unit, Sheba Medical Center, Israel

  Co-Author: Michal Stein, MD – Hillel Yaffe Medical Center

  Co-Author: Zohar Steinberg, md – Department of Pediatrics, Carmel Medical Center, Haifa, Israel.

  Co-Author: Shereen Shehadeh, md – Department of Pediatrics, Carmel Medical Center, Haifa, Israel.

  Presenting Author: Diana Tasher, MD (she/her/hers) – Pediatric Infectious Diseases Unit, Edith Wolfson Medical Center, Holon /Sackler School of Medicine, Tel-Aviv University
• 2:45 PM – 3:00 PM US ET

  Tolerability and Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Infants and Older Children in Global Studies
  

  Co-Author: Laurence Flint, MD – Pfizer Inc

  Presenting Author: Kathleen McElwee, MD, MDH (she/her/hers) – Pfizer Inc

  Co-Author: G. Laissa Ouedraogo, MD – Pfizer Inc

  Co-Author: Noor Tamimi, MD – Pfizer Inc

  Co-Author: Mary J. Kline, MD (she/her/hers) – Pfizer Inc

  Co-Author: Kimberly J. Center, M.D. – Pfizer

  Co-Author: Allison Thompson, MD – Pfizer Inc

  Co-Author: Richard de Solom, MBBS – Pfizer Australia

  Co-Author: Masako Yamaji, MS – Pfizer R&D Japan

  Co-Author: James Trammel, MS – Pfizer Inc

  Co-Author: Lanyu Lei, PhD – Pfizer Inc

  Co-Author: Yahong Peng, PhD – Pfizer Inc

  Co-Author: William C. Gruber, MD – Pfizer

  Co-Author: Daniel Scott, MD – Pfizer

  Co-Author: Wendy Watson, MD – Pfizer Vaccine Research and Development